Vera Therapeutics, Inc. (VERA) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $32.73 -1.83%
EPS Growth %: -27.8%
Financial Fact:
Total Costs and Operating Expenses: 3.84M
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -27.8%
Financial Fact:
Total Costs and Operating Expenses: 3.84M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q1 EPS of ($0.81), $0.08 worse than the analyst estimate of ($0.73).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Datadog, Inc. (DDOG) call put ratio 2.1 calls to 1 put with a focus on expiring September 270 puts as share price up 6.6%
- GoDaddy (GDDY) Reiterated at Buy by StoneX on Reports of Takeover Offer
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
